Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Pentixapharm Holding AG
Pentixapharm Announces IND Submission to FDA for Phase 3 PANDA Study of First-in-Class CXCR4-Targeted Cardiovascular Diagnostic
May 29, 2026
Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension
January 7, 2026